Skip to main content
. 2026 Feb 11;14(2):408. doi: 10.3390/biomedicines14020408
CML Chronic Myeloid Leukemia
IFN-α Interferon-alpha
Ph Philadelphia
TKI Tyrosine Kinase Inhibitor
Allo-HSCT Allogeneic Stem Cell Transplantation
OS Overall Survival
DMR Deep Molecular Response
TFR Treatment-Free Remission
QoL Quality of Life
CV Cardiovascular
CCyR Complete Cytogenetic Response
RT-qPCR Real-Time Quantitative Polymerase Chain Reaction
IS International Scale
IRIS International Randomized Study of Interferon and STI571
MMR Major Molecular Response
MR4 Molecular Response with a 4-log Reduction
MR4.5 Molecular Response with a 4.5-log Reduction
MR5 Molecular Response with a 5-log Reduction
ELN European LeukemiaNet
ACA Additional Chromosomal Abnormality
ddPCR Digital Droplet Polymerase Chain Reaction
NGS Next-Generation Sequencing
LSCs Leukemic Stem Cells
CVD Cardiovascular Death
KD Kinase Domain